MEditation for Post Stroke Depression



Status:Recruiting
Conditions:Depression, Depression, Neurology
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:November 15, 2017
End Date:September 1, 2019
Contact:Jennifer E Sanner, PhD
Email:Jennifer.E.Sanner@uth.tmc.edu
Phone:713-500-2114

Use our guide to learn which trials are right for you!

The purpose of this study is to establish the feasibility and acceptability of a breath-based
meditation in stroke survivors with post-stroke depression (PSD) and their informal
caregivers, as well as to examine the effects of the breath-based meditation. The hypothesis
is that the breath-based meditation will lead to decreases in the severity of symptoms of
PSD, post-stroke anxiety (PSA), and post-traumatic stress disorder (PTSD), and decreases in
plasma IL-1 pro-inflammatory cytokines post-intervention in stroke survivors with PSD and
their informal caregivers.


Inclusion Criteria:

- Stroke survivors will be included if they speak English, can provide written informed
consent, have a history of ischemic stroke, hemorrhagic, or transient ischemic attack
within the past 8 weeks, have a Center for Epidemiologic Studies-Depression (CES-D)
total score of 16 or greater suggestive of clinically significant depressive symptoms,
and currently live at home.

- Informal caregivers will be included if they are speak English, can provide written
informed consent, and self-identify as a first-time informal caregiver of a stroke
survivor. -

- To reflect standard practice, stroke survivors and their informal caregivers will be
eligible to participate in the study regardless of whether they are currently
receiving anti-depressant medications; however, the dose must have been stable for at
least one month prior to recruitment into the study.

Exclusion Criteria:

- Stroke survivors will be excluded if they currently reside outside of the home (e.g.,
rehabilitation center).

- Stroke survivors and their informal caregivers will be excluded if they have severe
cognitive impairment (Montreal Cognitive Assessment (MoCA) cutoff score of 20), active
psychosis, or bipolar disorder; if they currently abuse substances; or if they are
acutely suicidal. Those currently receiving formal psychotherapy or currently engaging
in self-identified meditation practices will also be excluded.
We found this trial at
1
site
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
Phone: 713-500-2114
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
?
mi
from
Houston, TX
Click here to add this to my saved trials